Skip to Main Content
Legislation Search

S. 4153: Forever Chemical Regulation and Accountability Act of 2026

The "Forever Chemical Regulation and Accountability Act of 2026" is legislation aimed at managing and regulating perfluoroalkyl and polyfluoroalkyl substances (PFAS), commonly referred to as "forever chemicals" due to their persistence in the environment and human body. The key components of the bill include:

Phaseout of Nonessential Uses

The bill seeks to phase out the nonessential uses of PFAS. This means that products containing these substances which are not deemed essential will no longer be allowed. Essential uses will be identified through a petition process, ensuring that only critical applications of PFAS can continue to be used.

Prohibition of Sale and Distribution

Sale and distribution of products containing PFAS will be prohibited within specified timelines. There are exceptions outlined for previously used products, indicating that certain items may still circulate in the market even after the ban on new products.

Regulatory Oversight and Accountability

The bill establishes a framework for regulatory oversight, where the Administrator is tasked with determining the format for required notices related to PFAS management. This includes the ability to act against immediate risks posed by these substances, ensuring that manufacturers or users provide immediate notifications to affected communities.

Legal Provisions

The legislation includes provisions for legal accountability, allowing courts to award litigation costs to winning parties in cases related to PFAS. This means that if a party successfully challenges a violation of the regulations, they could be compensated for their legal expenses. Additionally, courts may require bonds for restraining orders to ensure compliance.

Establishment of Analysis Centers

The bill mandates the creation of centers dedicated to analyzing and addressing PFAS contamination, particularly in water sources. These centers will ensure that municipalities and researchers have accessible tools for measuring contamination levels and will be responsible for reporting their activities to Congress annually until the program's termination, which is set for October 1, 2034, with the possibility of extension as needed.

Public Transparency

Throughout its implementation, the bill emphasizes public transparency and accountability in the management of PFAS. This includes making information available to the public regarding the identification of essential uses, the approval of products, and ongoing contamination assessments.

Timeline and Compliance

The legislation outlines specific timelines for compliance with the phaseout of nonessential PFAS uses and the restrictions on the sale and distribution of PFAS-containing products. This structured approach is intended to facilitate a smoother transition away from these substances while maintaining essential applications.

Community Involvement

Community engagement is a significant focus of the bill, with requirements for manufacturers and users to notify communities regarding any imminent risks associated with PFAS. This aspect highlights the importance of keeping the public informed about potential hazards related to chemical exposure.

Additional Reporting and Oversight

Annual reporting to Congress by the established analysis centers ensures that oversight continues throughout the lifespan of the initiatives under the bill. This reporting mechanism is designed to maintain accountability and evaluate the effectiveness of the phaseout strategies and contamination management efforts.

Relevant Companies

  • DOW - As a major manufacturer of chemicals, including PFAS, DOW may face new regulations that could impact its production processes and product offerings.
  • 3M - Known for its production of a wide range of products containing PFAS, 3M would need to adjust its manufacturing practices and potentially phase out certain products.
  • Chemours - Chemours, which specializes in chemical production including PFAS, could see significant changes in its operational strategies due to the phaseout requirements.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

1 sponsor

Actions

2 actions

Date Action
Mar. 19, 2026 Introduced in Senate
Mar. 19, 2026 Read twice and referred to the Committee on Environment and Public Works. (text: CR S1370-1380)

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Apr 07, 2026 Mar 10, 2026 -12.10%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Feb 06, 2026 Jan 06, 2026 +22.93%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
DOW logo
DOW DOW INC. COMMON STOCK
Purchase $1,001 - $15,000
Dec 15, 2025 Nov 18, 2025 +39.88%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Dec 08, 2025 Nov 03, 2025 +34.59%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Sep 09, 2025 Aug 26, 2025 +19.15%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Sep 09, 2025 Aug 26, 2025 +19.15%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Aug 07, 2025 Jul 25, 2025 +13.53%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Aug 07, 2025 Jul 25, 2025 +13.53%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Aug 07, 2025 Jul 01, 2025 -1.22%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Aug 07, 2025 Jul 01, 2025 -1.22%
Congress pfp
Lisa C. McClain R / House
CHE logo
CHE CHEMED CORP
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 24, 2025 -47.81%
Congress pfp
Lisa C. McClain R / House
DOW logo
DOW DOW INC. COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 24, 2025 -1.73%
Congress pfp
Michael T. McCaul R / House
DOW logo
DOW DOW INC REG
Sale $100,001 - $250,000
Jul 07, 2025 Jun 09, 2025 -11.33%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Jun 10, 2025 May 28, 2025 -9.65%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Jun 10, 2025 May 19, 2025 -15.10%
Congress pfp
Robert Bresnahan R / House
DOW logo
DOW DOW INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 09, 2025 May 15, 2025 -15.26%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
DOW logo
DOW DOW INC. COMMON STOCK
Sale $1,001 - $15,000
May 06, 2025 Apr 29, 2025 -26.39%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 23, 2025 -24.96%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 15, 2025 -18.92%
Congress pfp
Michael T. McCaul R / House
DOW logo
DOW DOW INC REG
Sale $100,001 - $250,000
May 12, 2025 Apr 10, 2025 -20.60%
Congress pfp
Byron Donalds R / House
CHE logo
CHE CHEMED CORP
Sale $1,001 - $15,000
Apr 14, 2025 Mar 06, 2025 -60.31%
Congress pfp
Byron Donalds R / House
CHE logo
CHE CHEMED CORP
Sale $1,001 - $15,000
Apr 14, 2025 Mar 06, 2025 -60.31%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 25, 2025 -41.25%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 -36.67%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 -44.34%
Congress pfp
Julie Johnson D / House
DOW logo
DOW DOW INC. COMMON STOCK
Purchase $1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 -44.06%
Congress pfp
Michael T. McCaul R / House
DOW logo
DOW DOW INC REG
Sale $100,001 - $250,000
Dec 16, 2024 Nov 20, 2024 -51.28%
Congress pfp
Michael T. McCaul R / House
DOW logo
DOW DOW INC REG
Sale $15,001 - $50,000
Dec 16, 2024 Nov 20, 2024 -51.28%
Congress pfp
Michael T. McCaul R / House
DOW logo
DOW DOW INC REG
Purchase $1,001 - $15,000
Sep 16, 2024 Aug 19, 2024 -72.31%
Congress pfp
Michael T. McCaul R / House
DOW logo
DOW DOW INC REG
Purchase $50,001 - $100,000
Sep 16, 2024 Aug 19, 2024 -72.31%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 05, 2024 -80.19%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 02, 2024 -77.07%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 02, 2024 -77.07%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -73.82%
Congress pfp
Ro Khanna D / House
DOW logo
DOW DOW INC CMN
Sale $1,001 - $15,000
Aug 07, 2024 Jul 01, 2024 -74.62%